Summary: “What the MDMA clearly did, is it allowed people to go into dark places where ordinarily they did not want to go,” says Bessel van der Kolk, M.D., a Principal Investigator of MAPS’ …
Summary: MAPS Harm Reduction Officer Sara Gael, M.A., zeroes in on the Zendo Project’s multifaceted approach to psychedelic harm reduction, which includes “education, training, and safety tools,” …
Summary: PSYCH of Prohibition Partners interviews MAPS Founder and Executive Director Rick Doblin, Ph.D., in honor of MAPS’ 35th anniversary. When asked what MAPS will be remembered for most, Doblin …
Summary: MAPS Policy and Advocacy Counsel Ismail L. Ali, J.D., highlights the challenges of obtaining legal permission for the religious use of psychedelics in this Rolling Stone article: “The core thing …
Summary: In an engaging editorial for the British Medical Journal (BMJ) Opinion, Peter Brindley, M.D., encourages “scientific skeptic[s]” to “accept and celebrate the chance to change …
Summary: In the Spring 2021 edition of the Stanford Social Innovation Review, journalist Marc Gunther dives into the decades-long history of MAPS, discussing its founding in 1986 by Rick Doblin, Ph.D., …
Summary: The Guardian details the introduction of California’s psychedelic decriminalization bill by State Senator Scott Wiener, who believes that “people should not be going to jail for possessing …
Summary: Lucid News contributor Colleen Newvine profiles MAPS Major Gifts Officer and Connector Jade Netanya Ullmann. This article provides a window into the life of a highly successful and iconically …
Summary: In Rolling Stone, the co-founders of DoubleBlind consider the prospect of federal drug policy changes surrounding psychedelics under President Joe Biden and a new Congress. MAPS Director of Policy …
Summary: Maya Singer of Vogue interweaves an explanation of the groundbreaking progress in the expanding psychedelic field and her personal experience with ketamine therapy via telemedicine. Singer interviews …
Summary: Nature reports on the growing field of psychedelics, citing the increase in clinical trials involving psychedelics, decriminalization efforts in the United States, establishment of psychedelic …
Summary: In Psychology Today, Sarah Rose Siskind outlines the ways in which people can benefit from psychedelics without actually consuming them. One of these possible advantages, Siskind argues, is that …
